Management of immune checkpoint inhibitor‐related adverse events: A review of case reports

Immune checkpoint inhibitors represent a major breakthrough in cancer therapy. Immune‐related adverse events (irAEs) may occur during treatment due to their unique mechanism of action. Management of irAEs is based on clinical experience because it is not easy to conduct prospective trials to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Xiaoyan, Song, Peng, Ni, Jun, Di, Mingyi, He, Chunxia, Zhang, Li, Liu, Xiaowei, Li, Yue, Wang, Hanping, Guo, Xiaoxiao, Zhou, Jiaxin, Duan, Lian, Yang, Xu, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049490/
https://www.ncbi.nlm.nih.gov/pubmed/31970923
http://dx.doi.org/10.1111/1759-7714.13315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049490/
https://www.ncbi.nlm.nih.gov/pubmed/31970923
http://dx.doi.org/10.1111/1759-7714.13315

Ejemplares similares